Literature DB >> 3857114

Switch in differentiative response to maturation inducers of human promyelocytic leukemia cells by prior exposure to alkaline conditions.

S A Fischkoff, M E Condon.   

Abstract

The myeloid lineage to which HL-60 promyelocytic leukemia cells will differentiate in response to a chemical differentiation inducer can be switched by altering the pH of the growth medium. Cells passaged previously at pH 7.2 become neutrophiles, and those passaged previously at pH 7.6 become eosinophiles after 5 to 7 days of culture in the presence of 0.5 mM butyric acid. Butyric acid and its analogues are unique in that all other chemical maturation inducers tested, such as dimethyl sulfoxide and retinoic acid, promote neutrophilic differentiation regardless of the prior culture history of the cells. This suggests that lineage commitment and maturational commitment are mechanistically separate processes in this multipotential cell line and can be independently manipulated experimentally.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3857114

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Butyric acid: inhibition of non-leukemic and chronic myeloid leukemia granulocyte macrophage clonal growth.

Authors:  E Januszewicz; E Rabizadah; A Novogrodsky; M Shaklai
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

2.  Natural forms of vitamin E and 13'-carboxychromanol, a long-chain vitamin E metabolite, inhibit leukotriene generation from stimulated neutrophils by blocking calcium influx and suppressing 5-lipoxygenase activity, respectively.

Authors:  Ziying Jiang; Xinmin Yin; Qing Jiang
Journal:  J Immunol       Date:  2010-12-17       Impact factor: 5.422

3.  The effect of eosinophils on collagen gel contraction and implications for tissue remodelling.

Authors:  U Zagai; C M Sköld; A Trulson; P Venge; J Lundahl
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 4.  Galectin-9 in physiological and pathological conditions.

Authors:  Mitsuomi Hirashima; Yumiko Kashio; Nozomu Nishi; Akira Yamauchi; Tada-atsu Imaizumi; Toshiro Kageshita; Naoki Saita; Takanori Nakamura
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

5.  Transcription Factor Repertoire of Homeostatic Eosinophilopoiesis.

Authors:  Carine Bouffi; Andrey V Kartashov; Kaila L Schollaert; Xiaoting Chen; W Clark Bacon; Matthew T Weirauch; Artem Barski; Patricia C Fulkerson
Journal:  J Immunol       Date:  2015-08-12       Impact factor: 5.422

6.  Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.

Authors:  Kenji Ishihara; JangJa Hong; OkPyo Zee; Kazuo Ohuchi
Journal:  Br J Pharmacol       Date:  2004-06-21       Impact factor: 8.739

Review 7.  Role of Short Chain Fatty Acids and Apolipoproteins in the Regulation of Eosinophilia-Associated Diseases.

Authors:  Eva Maria Sturm; Eva Knuplez; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

8.  Characterization of interleukin 5 receptors on eosinophilic sublines from human promyelocytic leukemia (HL-60) cells.

Authors:  G Plaetinck; J Van der Heyden; J Tavernier; I Faché; T Tuypens; S Fischkoff; W Fiers; R Devos
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

9.  Sweet taste receptor agonists attenuate macrophage IL-1β expression and eosinophilic inflammation linked to autophagy deficiency in myeloid cells.

Authors:  Jinju Lee; So Jeong Kim; Go Eun Choi; Eunbi Yi; Hyo Jin Park; Woo Seon Choi; Yong Ju Jang; Hun Sik Kim
Journal:  Clin Transl Med       Date:  2022-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.